Skip to main content
FinSpry Logo
FinSpry
NVO logo
NVO
(NYSE)
Novo Nordisk A/S
$47.26-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Novo Nordisk A/S (NVO) Stock Price & Financial Analysis

Novo Nordisk A/S Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$46.73 - $47.50
52-Week High$64.16
52-Week Low$35.12
Open$47.15
Volume11.81M
Average Volume (3M)11.81M
Market Cap210.25B
Shares Outstanding4.45B
P/E Ratio (TTM)11.15
Forward P/E9.56
Price to Sales (P/S)4.15
Price to Book (P/B)6.70
EV/EBITDA8.23
Revenue (TTM)50.69B
Net Income (TTM)18.86B
Free Cash Flow (TTM)4.93B
EPS (TTM)$4.24
Profit Margin37.20%
Operating Margin45.30%
Return on Equity (ROE)60.06%
Debt to Equity0.72
50-Day MA$46.96
200-Day MA$46.69
52-Week Change-3.08%
Annual Dividend$2.94
Dividend Yield6.23%
Payout Ratio69.44%
Last Dividend Ex-DateApr 8, 2027

Frequently Asked Questions About Novo Nordisk A/S

What is the current stock price for NVO?

As of the latest trading session, NVO stock trades at $47.26. The 52-week range is $35.12–$64.16, with a day range of $46.73–$47.50.

What is the P/E ratio for NVO?

Novo Nordisk A/S's trailing P/E ratio is 11.2, meaning investors pay $11.2 for every $1 of annual earnings. The forward P/E is 9.6, reflecting analyst expectations for future earnings. Novo Nordisk A/S operates in the Healthcare sector.

Does NVO pay dividends?

Yes, Novo Nordisk A/S pays a 6.23% annual dividend yield ($2.94 per share). The payout ratio is 69.4%. The last ex-dividend date was 2027-04-08.

What do analysts recommend for NVO?

Based on 4 analysts, the consensus for NVO is Hold.

What is the market cap of NVO?

Novo Nordisk A/S's market capitalization is $210.25B, classifying it as a mega-cap company. Novo Nordisk A/S operates in the Healthcare sector within the Drug Manufacturers - General industry.